`Q5134` Inj, tyruko, 1 mg

Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg

Medicare coverage: Carrier judgment
Status: active (July 2026 file)
MUE: max 300 units per day (practitioner), rationale: Prescribing Information